Michael Ayodele Odeniyi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Ayodele Odeniyi has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Obukowho Emikpe
Department of Pathobiology, School of Veterinary Medicine, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana
7 shared publications - Olubusola Ayoola Odeniyi
Department of Microbiology, University of Ibadan, Nigeria
5 shared publications - Tioluwani Ibukun Adegbolagun
Department of Pharmaceutics And Industrial Pharmacy, University of Ibadan, Nigeria
4 shared publications John Oluwasogo Ayorinde
Department of Pharmaceutics and Industrial Pharmacy, University of Ibadan, Ibadan, Nigeria
3 shared publicationsK T Jaiyeoba
3 shared publicationsOludele Adelanwa Itiola
3 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 10
Green synthesis, characterization, and antimicrobial evaluation of jackfruit seed starch-capped copper oxide nanoparticles in cold creams
- 7 August 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 10
Open AccessGreen synthesis, characterization, and antimicrobial evaluation of jackfruit seed starch-capped copper oxide nanoparticles in cold creams
- Open Access
- 28 April 2026
- Published by Ataturk Universitesi in Veterinary Sciences and Practices
- Vol. 21 (1) , 16-25
Newcastle Disease Vaccination using Mucoadhesive and Conventional Oral Delivery in Commercial Broilers: Serological, Heterophil: Lymphocyte ratio and Lymphoid Histopathological Changes
Newcastle Disease (ND) threatens poultry productivity worldwide. Vaccination remains central to control, but conventional oral delivery often yields short-lived immunity. Mucoadhesive systems are an alternative delivery method that improves mucosal antigen retention and immunogenicity. This study compared the serological, physiological, and immunoarchitectural responses of broiler chickens administered oral vaccination against ND with local or imported LaSota strains delivered either in water or via cashew gum-alginate microbeads. One hundred and five broiler chicks were assigned to six groups: unvaccinated controls, blank microbeads, imported LaSota in water (ILW) or microbeads (IML), and local LaSota in water (LLW) or microbeads (LML). Immune responses were assessed using hemagglutination inhibition (HI) assay, heterophil-to-lymphocyte (H:L) ratio, and histopathology of lymphoid tissues. The mucoadhesive local LaSota group (LML) produced the highest and most durable antibody titres (GMT ≥ 203.2, 14 and 35 days post-vaccination), significantly outperforming all others (P < .05). LLW peaked earlier but decayed rapidly, while imported vaccines (ILW, IML) showed weak responses. Histopathology revealed strong germinal centre formation in the spleen and jejunum of mucoadhesive groups. H:L ratios were significantly lower in these groups (P < .05), suggesting potent immunity without physiological stress. Growth performance was unaffected across treatments. Mucoadhesive microbeads enhanced ND vaccine efficacy by sustaining antibody production, improving lymphoid organization, and reducing stress. The superior response of the local strain emphasizes the importance of antigenic alignment with circulating variants. Results provide serological, histological, and welfare evidence for adopting mucoadhesive delivery as a practical strategy in ND control, particularly for backyard poultry.
- 28 April 2026
- Published by Ataturk Universitesi in Veterinary Sciences and Practices
- Vol. 21 (1) , 16-25
Open AccessNewcastle Disease Vaccination using Mucoadhesive and Conventional Oral Delivery in Commercial Broilers: Serological, Heterophil: Lymphocyte ratio and Lymphoid Histopathological Changes
Newcastle Disease (ND) threatens poultry productivity worldwide. Vaccination remains central to control, but conventional oral delivery often yields short-lived immunity. Mucoadhesive systems are an alternative delivery method that improves mucosal antigen retention and immunogenicity. This study compared the serological, physiological, and immunoarchitectural responses of broiler chickens administered oral vaccination against ND with local or imported LaSota strains delivered either in water or via cashew gum-alginate microbeads. One hundred and five broiler chicks were assigned to six groups: unvaccinated controls, blank microbeads, imported LaSota in water (ILW) or microbeads (IML), and local LaSota in water (LLW) or microbeads (LML). Immune responses were assessed using hemagglutination inhibition (HI) assay, heterophil-to-lymphocyte (H:L) ratio, and histopathology of lymphoid tissues. The mucoadhesive local LaSota group (LML) produced the highest and most durable antibody titres (GMT ≥ 203.2, 14 and 35 days post-vaccination), significantly outperforming all others (P < .05). LLW peaked earlier but decayed rapidly, while imported vaccines (ILW, IML) showed weak responses. Histopathology revealed strong germinal centre formation in the spleen and jejunum of mucoadhesive groups. H:L ratios were significantly lower in these groups (P < .05), suggesting potent immunity without physiological stress. Growth performance was unaffected across treatments. Mucoadhesive microbeads enhanced ND vaccine efficacy by sustaining antibody production, improving lymphoid organization, and reducing stress. The superior response of the local strain emphasizes the importance of antigenic alignment with circulating variants. Results provide serological, histological, and welfare evidence for adopting mucoadhesive delivery as a practical strategy in ND control, particularly for backyard poultry.
- 29 November 2025
- Published by Wiley in Starch - Stärke
- Vol. 77 (12)
Green Synthesis and Antibacterial Properties of Native and Pregelatinized Bitter Yam Starch‐Zinc Oxide Nanoparticles and Their Oral Dissolving Films
Starches have gained attention for the green synthesis of zinc oxide nanoparticles (ZnO NPs) as reducing and capping agents. This study investigates the potential of native and pregelatinized starches of bitter yam in the green synthesis of ZnO NPs. Two methods—full green synthesis (FGS) and partial green synthesis (PGS) —were employed to produce ZnO NPs that were characterized by UV‐visible spectrophotometry, atomic absorption spectroscopy, FT‐IR, XRD, DSC, and antibacterial assays. The ZnO NPs synthesized through FGS had smaller particle sizes, and XRD spectra showed identical diffraction peaks characteristic of the wurtzite structure at 26.8°, 31.9°, 34.6°, and 36.4°. Major UV absorption peaks were observed at ∼300 nm. The FTIR spectra of the FGS nanoparticles were different from those of PGS, with major peaks around 3300–3400, 2800–3000, 1000–1200, and 400–600 cm −1 . The pregelatinized starch‐ZnO NPs synthesized via FGS showed higher antibacterial activities, with MIC and MBC values as low as 2.5 and 1.25 mg/mL, respectively. Nanoparticle‐loaded oral dissolving films also demonstrated antibacterial activities against Pseudomonas aeruginosa , Staphylococcus aureus , and Escherichia coli , supporting their potential use for oral antibacterial applications. Pregelatinized and native bitter yam starches are adequate reducing and capping biomaterials for the green synthesis of ZnO NPs.
- 29 November 2025
- Published by Wiley in Starch - Stärke
- Vol. 77 (12)
Green Synthesis and Antibacterial Properties of Native and Pregelatinized Bitter Yam Starch‐Zinc Oxide Nanoparticles and Their Oral Dissolving Films
Starches have gained attention for the green synthesis of zinc oxide nanoparticles (ZnO NPs) as reducing and capping agents. This study investigates the potential of native and pregelatinized starches of bitter yam in the green synthesis of ZnO NPs. Two methods—full green synthesis (FGS) and partial green synthesis (PGS) —were employed to produce ZnO NPs that were characterized by UV‐visible spectrophotometry, atomic absorption spectroscopy, FT‐IR, XRD, DSC, and antibacterial assays. The ZnO NPs synthesized through FGS had smaller particle sizes, and XRD spectra showed identical diffraction peaks characteristic of the wurtzite structure at 26.8°, 31.9°, 34.6°, and 36.4°. Major UV absorption peaks were observed at ∼300 nm. The FTIR spectra of the FGS nanoparticles were different from those of PGS, with major peaks around 3300–3400, 2800–3000, 1000–1200, and 400–600 cm −1 . The pregelatinized starch‐ZnO NPs synthesized via FGS showed higher antibacterial activities, with MIC and MBC values as low as 2.5 and 1.25 mg/mL, respectively. Nanoparticle‐loaded oral dissolving films also demonstrated antibacterial activities against Pseudomonas aeruginosa , Staphylococcus aureus , and Escherichia coli , supporting their potential use for oral antibacterial applications. Pregelatinized and native bitter yam starches are adequate reducing and capping biomaterials for the green synthesis of ZnO NPs.
- Open Access
- 1 July 2025
- Published by Wroclaw Medical University in Polymers in Medicine
- Vol. 55 (1) , 7-19
Native and pregelatinized starches of bitter yam as film formers for oral dissolving formulations
Polymers in Medicine – a peer-reviewed scientific journal published by Wrocław Medical University, focusing on research on the application of polymers in medicine, pharmacy, and biomaterials.
- 1 July 2025
- Published by Wroclaw Medical University in Polymers in Medicine
- Vol. 55 (1) , 7-19
Open AccessNative and pregelatinized starches of bitter yam as film formers for oral dissolving formulations
Polymers in Medicine – a peer-reviewed scientific journal published by Wrocław Medical University, focusing on research on the application of polymers in medicine, pharmacy, and biomaterials.
- 9 February 2025
- Published by Wiley in Starch - Stärke
- Vol. 77 (5)
Thiolated and Carboxymethylated Jackfruit Seed Starch Nanocrystals as Polymeric Drug Carriers for Curcumin Delivery to Cancer Cells
Jackfruit seeds are rich in starch and can be used as an alternative source of the polymer. Starch nanocrystals can act as a carrier to improve curcumin's anti‐cancer effect. This study evaluated modified jackfruit starch nanocrystals as carriers for delivering curcumin to MCF‐7 breast cancer cell lines. Nanocrystals were prepared by acid hydrolysis and modified by carboxymethylation and thiolation. The starch forms were characterized by scanning electron microscopy, X‐ray diffraction, Fourier transform infrared spectroscopy, drug loading, mucoadhesion, and toxicity. Curcumin‐loaded starches were evaluated for in vitro drug release and cytotoxicity on MCF‐7 cancer cells. The prepared nanocrystals had an average particle size of 6.15 ± 0.80 nm, with altered morphology after modification. The starch's crystallinity (27.18%) increased with acid hydrolysis (37.54%) and thiolation (41.37%) but decreased with carboxymethylation (23.29%). The highest drug loading (70.23% ± 0.23%) was recorded for carboxymethylated nanocrystals, then thiolated nanocrystals (63.37% ± 0.40%), and the lowest (49.31% ± 0.13%) was for the native starch. Mucoadhesion was improved by thiolation, and the curcumin‐loaded thiolated nanocrystals produced an IC50 value (42.5 ± 0.12 µm/mL) lower than plain curcumin (86.80 ± 0.10 µm/mL). Modified jackfruit starch nanocrystals possess acceptable properties and are potential candidates for the effective delivery of curcumin to cancer cells.
- 9 February 2025
- Published by Wiley in Starch - Stärke
- Vol. 77 (5)
Thiolated and Carboxymethylated Jackfruit Seed Starch Nanocrystals as Polymeric Drug Carriers for Curcumin Delivery to Cancer Cells
Jackfruit seeds are rich in starch and can be used as an alternative source of the polymer. Starch nanocrystals can act as a carrier to improve curcumin's anti‐cancer effect. This study evaluated modified jackfruit starch nanocrystals as carriers for delivering curcumin to MCF‐7 breast cancer cell lines. Nanocrystals were prepared by acid hydrolysis and modified by carboxymethylation and thiolation. The starch forms were characterized by scanning electron microscopy, X‐ray diffraction, Fourier transform infrared spectroscopy, drug loading, mucoadhesion, and toxicity. Curcumin‐loaded starches were evaluated for in vitro drug release and cytotoxicity on MCF‐7 cancer cells. The prepared nanocrystals had an average particle size of 6.15 ± 0.80 nm, with altered morphology after modification. The starch's crystallinity (27.18%) increased with acid hydrolysis (37.54%) and thiolation (41.37%) but decreased with carboxymethylation (23.29%). The highest drug loading (70.23% ± 0.23%) was recorded for carboxymethylated nanocrystals, then thiolated nanocrystals (63.37% ± 0.40%), and the lowest (49.31% ± 0.13%) was for the native starch. Mucoadhesion was improved by thiolation, and the curcumin‐loaded thiolated nanocrystals produced an IC50 value (42.5 ± 0.12 µm/mL) lower than plain curcumin (86.80 ± 0.10 µm/mL). Modified jackfruit starch nanocrystals possess acceptable properties and are potential candidates for the effective delivery of curcumin to cancer cells.
- Open Access
- 15 May 2024
- Published by MDPI AG in Proceedings
- Vol. 107 (1) , 42
The Use of Plant-Derived Biomaterials as Drug Formulation Excipients: An Application of Biomimetics in Dosage Form Development
To develop an active drug into a suitable dosage form, pharmaceutical scientists combine various excipients (additives) obtained from different sources
- 15 May 2024
- Published by MDPI AG in Proceedings
- Vol. 107 (1) , 42
Open AccessThe Use of Plant-Derived Biomaterials as Drug Formulation Excipients: An Application of Biomimetics in Dosage Form Development
To develop an active drug into a suitable dosage form, pharmaceutical scientists combine various excipients (additives) obtained from different sources
- 5 April 2024
- Published by Wiley in Starch - Stärke
- Vol. 76 (9-10) , 2400022
Characterization and Drug Release Properties of Curcumin Loaded Native and Nano‐Sized Starches of Pigeon Pea (Cajanus cajan) and Bambara Nut (Vigna subterranean)
Starches from underutilized sources such as Bambara nut (BAM) and pigeon pea (PP) can serve as new sources of starch. Starch nanoparticles (SNP) of BAM (BAMnp) and PP (PPnp) are prepared by nanoprecipitation. The physicochemical and pasting properties of the native and SNP are evaluated. The scanning electron microscopy, fourier transform infrared spectroscopy (FTIR), X‐ray diffraction (XRD), drug loading, and release studies of curcumin‐loaded starches and SNP are carried out. The flow, swelling, and solubility of the native starches improve with nanoparticle fabrication. Setback viscosities of the starches are in the order PPnp < BAMnp < PP < BAM. The integrity of the starch granules is maintained after modification. The FTIR of loaded starches shows no interaction between the entities. Reduction in crystallinity of the SNP is observed in the XRD diffractogram. The drug loading efficiency of BAM, PP, BAMnp, and PPnp are 48.55 ± 0.11, 49.00 ± 0.11, 55.44 ± 0.40, and 54.72 ± 0.11, respectively. The drug release is improved when curcumin is loaded on the SNP. The release after 6 h is 33%, 25%, and 2% for BAMnp, PPnp, and pure curcumin, respectively. The properties of the SNP showed that they are potential candidates for the delivery of curcumin, a poorly water soluble drug.
- 5 April 2024
- Published by Wiley in Starch - Stärke
- Vol. 76 (9-10) , 2400022
Characterization and Drug Release Properties of Curcumin Loaded Native and Nano‐Sized Starches of Pigeon Pea (Cajanus cajan) and Bambara Nut (Vigna subterranean)
Starches from underutilized sources such as Bambara nut (BAM) and pigeon pea (PP) can serve as new sources of starch. Starch nanoparticles (SNP) of BAM (BAMnp) and PP (PPnp) are prepared by nanoprecipitation. The physicochemical and pasting properties of the native and SNP are evaluated. The scanning electron microscopy, fourier transform infrared spectroscopy (FTIR), X‐ray diffraction (XRD), drug loading, and release studies of curcumin‐loaded starches and SNP are carried out. The flow, swelling, and solubility of the native starches improve with nanoparticle fabrication. Setback viscosities of the starches are in the order PPnp < BAMnp < PP < BAM. The integrity of the starch granules is maintained after modification. The FTIR of loaded starches shows no interaction between the entities. Reduction in crystallinity of the SNP is observed in the XRD diffractogram. The drug loading efficiency of BAM, PP, BAMnp, and PPnp are 48.55 ± 0.11, 49.00 ± 0.11, 55.44 ± 0.40, and 54.72 ± 0.11, respectively. The drug release is improved when curcumin is loaded on the SNP. The release after 6 h is 33%, 25%, and 2% for BAMnp, PPnp, and pure curcumin, respectively. The properties of the SNP showed that they are potential candidates for the delivery of curcumin, a poorly water soluble drug.
- Open Access
- 19 December 2023
- Published by Wroclaw Medical University in Polymers in Medicine
- Vol. 53 (2) , 117-127
Drug delivery applications and future prospects of microbial exopolysaccharides
Over the years, exopolysaccharides (EPSs) have been utilized in various areas of research, including health, industry, environment, and agriculture, due to their flexible physical, chemical and structural properties that can be readily modified to suit desired purposes. Current research trends have shown that EPS production is dependent on numerous factors which can be combined to varying extent to optimize production yields. Although the majority of research is directed towards their industrial and medicinal uses, these chemical substances possess peculiar characteristics which are also exploited for biomedical research, where they are being used as drug delivery systems, some of which include their abundance in nature, biocompatibility, biodegradability, non-toxicity, and ability to efficiently encapsulate sensitive bioactive agents. However, despite the numerous beneficial prospects of microbial EPSs in drug delivery, there are limitations to the commercial production and industrial applications of these biopolymers. These limitations have inspired revolutionary research into the cost-effective production of safe EPSs polymers. In this review, we classify EPSs and discuss their methods of extraction and characterization. We also summarized current drug delivery applications and discussed limitations to extensive industrial commercialization of EPSs, while highlighting prospects for the utilization of microbial EPSs and implications for research.
- 19 December 2023
- Published by Wroclaw Medical University in Polymers in Medicine
- Vol. 53 (2) , 117-127
Open AccessDrug delivery applications and future prospects of microbial exopolysaccharides
Over the years, exopolysaccharides (EPSs) have been utilized in various areas of research, including health, industry, environment, and agriculture, due to their flexible physical, chemical and structural properties that can be readily modified to suit desired purposes. Current research trends have shown that EPS production is dependent on numerous factors which can be combined to varying extent to optimize production yields. Although the majority of research is directed towards their industrial and medicinal uses, these chemical substances possess peculiar characteristics which are also exploited for biomedical research, where they are being used as drug delivery systems, some of which include their abundance in nature, biocompatibility, biodegradability, non-toxicity, and ability to efficiently encapsulate sensitive bioactive agents. However, despite the numerous beneficial prospects of microbial EPSs in drug delivery, there are limitations to the commercial production and industrial applications of these biopolymers. These limitations have inspired revolutionary research into the cost-effective production of safe EPSs polymers. In this review, we classify EPSs and discuss their methods of extraction and characterization. We also summarized current drug delivery applications and discussed limitations to extensive industrial commercialization of EPSs, while highlighting prospects for the utilization of microbial EPSs and implications for research.
- Open Access
- 26 June 2021
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 7 (1) , 1-10
Drug delivery applications of poly-γ-glutamic acid
Background: Poly-γ-glutamic acid (γ-PGA) is a biopolymer of microbial origin, consisting of repeating units of l-glutamic acid and/or D-glutamic acid. The biopolymer has found use in the fields of agriculture, food, wastewater, and medicine, owing to its non-toxic, biodegradable, and biocompatible properties. Due to its biodegradability, γ-PGA is being tipped to dislodge synthetic plastics in drug delivery application. High cost of production, relative to plastics, is however a clog in the wheel of achieving this. Main body of This review looked at the production, nanoparticles fabrication, and drug delivery application of γ-PGA. γ-PGA production optimization by modifying the fermentation medium to tailor towards the production of desirable polymer at reduced cost and techniques for the formulation of γ-PGA nanoparticle as well as its characterization were discussed. This review also evaluated the application of γ-PGA and its nanoparticles in the delivery of drugs to action site. Characterization of γ-PGA and its nanoparticles is a crucial step towards determining the applicability of the biopolymer. γ-PGA has been used in the delivery of active agents to action sites. Conclusion: This review highlights some of the efforts that have been made in the appraisal of γ-PGA and its nanoparticles for drug delivery. γ-PGA is a candidate for future extensive use in drug delivery.
- 26 June 2021
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 7 (1) , 1-10
Open AccessDrug delivery applications of poly-γ-glutamic acid
Background: Poly-γ-glutamic acid (γ-PGA) is a biopolymer of microbial origin, consisting of repeating units of l-glutamic acid and/or D-glutamic acid. The biopolymer has found use in the fields of agriculture, food, wastewater, and medicine, owing to its non-toxic, biodegradable, and biocompatible properties. Due to its biodegradability, γ-PGA is being tipped to dislodge synthetic plastics in drug delivery application. High cost of production, relative to plastics, is however a clog in the wheel of achieving this. Main body of This review looked at the production, nanoparticles fabrication, and drug delivery application of γ-PGA. γ-PGA production optimization by modifying the fermentation medium to tailor towards the production of desirable polymer at reduced cost and techniques for the formulation of γ-PGA nanoparticle as well as its characterization were discussed. This review also evaluated the application of γ-PGA and its nanoparticles in the delivery of drugs to action site. Characterization of γ-PGA and its nanoparticles is a crucial step towards determining the applicability of the biopolymer. γ-PGA has been used in the delivery of active agents to action sites. Conclusion: This review highlights some of the efforts that have been made in the appraisal of γ-PGA and its nanoparticles for drug delivery. γ-PGA is a candidate for future extensive use in drug delivery.